Auditory mismatch negativity deficits in long-term heavy cannabis users

被引:24
作者
Roser, Patrik [1 ]
Della, Beate [1 ]
Norra, Christine [1 ]
Uhl, Idun [1 ]
Bruene, Martin [1 ]
Juckel, Georg [1 ]
机构
[1] Ruhr Univ Bochum, Dept Psychiat, D-44791 Bochum, Germany
关键词
Cannabis; Long-term effects; Cognitive deficits; Event-related potentials; Mismatch negativity; COMORBID SUBSTANCE-ABUSE; EVENT-RELATED POTENTIALS; SELECTIVE-ATTENTION; SCHIZOPHRENIA; MEMORY; GENERATION; DELTA-9-TETRAHYDROCANNABINOL; IMPAIRMENTS; CONSTITUENT; DYSFUNCTION;
D O I
10.1007/s00406-010-0097-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mismatch negativity (MMN) is an auditory event-related potential indicating auditory sensory memory and information processing. The present study tested the hypothesis that chronic cannabis use is associated with deficient MMN generation. MMN was investigated in age- and gender-matched chronic cannabis users (n = 30) and nonuser controls (n = 30). The cannabis users were divided into two groups according to duration and quantity of cannabis consumption. The MMNs resulting from a pseudorandomized sequence of 2 x 900 auditory stimuli were recorded by 32-channel EEG. The standard stimuli were 1,000 Hz, 80 dB SPL and 90 ms duration. The deviant stimuli differed in duration (50 ms) or frequency (1,200 Hz). There were no significant differences in MMN values between cannabis users and nonuser controls in both deviance conditions. With regard to subgroups, reduced amplitudes of frequency MMN at frontal electrodes were found in long-term (a parts per thousand yen8 years of use) and heavy (a parts per thousand yen15 joints/week) users compared to short-term and light users. The results indicate that chronic cannabis use may cause a specific impairment of auditory information processing. In particular, duration and quantity of cannabis use could be identified as important factors of deficient MMN generation.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 52 条
[1]  
[Anonymous], 1994, Diagnostic and Statistical Manual of Mental Disorders
[2]   Dose-related neurocognitive effects of marijuana use [J].
Bolla, KI ;
Brown, K ;
Eldreth, D ;
Tate, K ;
Cadet, JL .
NEUROLOGY, 2002, 59 (09) :1337-1343
[3]  
BROWN J, 1992, BRIT J ADDICT, V87, P1013
[4]   Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction [J].
D'Souza, DC ;
Abi-Saab, WM ;
Madonick, S ;
Forselius-Bielen, K ;
Doersch, A ;
Braley, G ;
Gueorguieva, R ;
Cooper, TB ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2005, 57 (06) :594-608
[5]   Cannabis and psychosis/schizophrenia: human studies [J].
D'Souza, Deepak Cyril ;
Sewell, Richard Andrew ;
Ranganathan, Mohini .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (07) :413-431
[6]   Cannabinoids and psychosis [J].
D'Souza, Deepak Cyril .
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 :289-+
[7]   The endocannabinoid system: Physiology and pharmacology [J].
de Fonseca, FR ;
Del Arco, I ;
Bermudez-Silva, FJ ;
Bilbao, A ;
Cippitelli, A ;
Navarro, M .
ALCOHOL AND ALCOHOLISM, 2005, 40 (01) :2-14
[8]   Chemical constituents of marijuana: The complex mixture of natural cannabinoids [J].
ElSohly, MA ;
Slade, D .
LIFE SCIENCES, 2005, 78 (05) :539-548
[9]   Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system [J].
Emrich, HM ;
Leweke, FM ;
Schneider, U .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (04) :803-807
[10]   ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH [J].
GAONI, Y ;
MECHOULAM, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1646-+